At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

POSITION SUMMARY:

We are seeking a Senior Brand Manager to lead the development and execution of marketing strategies for two areas within our rare diseases team: Pulmonary Arterial Hypertension (PAH) and Autoantibody Diseases (Nipocalimab/Imaavy). This role combines critical thinking with operational delivery, with a strong focus on crafting brand plans that resonate with healthcare professionals and drive impact in sophisticated, specialty markets.
The ideal candidate is someone who takes ownership, brings their own perspective to strategic and tactical discussions, and is comfortable challenging the status quo when needed. We’re looking for someone who is hands-on, yet forward-looking—capable of delivering on today’s priorities while contributing to the strategic direction of the brands.

• Develop and implement marketing plans for PAH and Nipocalimab (Imaavy), in close alignment with cross-functional teams and regional/global partners.
• Lead positioning, messaging, and content development tailored to the needs of specialist audiences.
• Bring market insights and field feedback into strategy discussions and identify opportunities to differentiate and improve brand performance.
• Design and roll out omnichannel campaigns and promotional initiatives, ensuring consistency and compliance across channels.
• Collaborate closely with medical, market access & sales to drive coordinated execution.
• Propose and implement new ideas to improve customer engagement or strengthen brand relevance.
• Measure the impact of marketing activities and contribute to business reviews with clear, data-driven insights.
• PAH: actively identify and implement creative brand strategies & tactics to differentiate the portfolio from competitors, ensuring a strong and sustainable competitive edge in the PAH market.
• Nipocalimab (Imaavy) launch: Play a key role in the development & execution of our launch plan and build impactful marketing assets for Nipocalimab/Imaavy, striving to deliver an outstanding product introduction in Myasthenia Gravis.